Globus Medical (GMED) PT Raised to $117 at Needham May 8, 2026 06:18AM
Globus Medical (GMED) PT Raised to $114 at Needham Feb 25, 2026 07:10AM
Needham Upgrades Globus Medical (GMED) to Buy, 'Analysis Indicates Earnings Upside & Favorable Risk/Reward' Jan 30, 2026 06:45AM
Needham Reiterates Hold Rating on Globus Medical (GMED) Nov 7, 2025 05:17AM
Needham Reiterates Hold Rating on Globus Medical (GMED) Jul 21, 2025 10:52AM


Feb 6, 2025 12:43PM Needham Reiterates Hold Rating on Globus Medical (GMED)
Nov 6, 2024 06:10AM Needham Reiterates Hold Rating on Globus Medical (GMED)
May 5, 2021 06:25AM Globus Medical (GMED) PT Raised to $82 at Needham & Company
Feb 18, 2021 07:57AM Globus Medical (GMED) Offers Light Guidance but Needham Sees Through Chatter and Raises PT to $75
Nov 7, 2019 06:47AM Globus Medical (GMED) PT Raised to $63 at Needham & Company
Aug 2, 2019 08:10AM Globus Medical (GMED) PT Raised to $56 at Needham & Company
Feb 6, 2019 07:46AM Globus Medical (GMED) PT Lowered to $57 at Needham & Company
Aug 2, 2018 08:15AM Globus Medical (GMED) PT Raised to $65 at Needham & Company
May 3, 2018 06:38AM Globus Medical (GMED) PT Raised to $58 at Needham & Company
Apr 4, 2018 05:38AM Needham & Company Upgrades Globus Medical (GMED) to Buy
Oct 9, 2017 01:01PM K2M Warning is a Negative Read-Through for Globus Medical (GMED) and NuVasive (NUVA) - Needham & Company
Sep 26, 2017 04:16PM UPDATE: Needham & Company Starts Globus Medical (GMED) at Hold
Sep 11, 2014 10:39AM Notable Analyst Rating Changes 9/11: (VRA) (WCC) (AAWW) Upgraded; (M) (EOPN) (ESRX) Downgraded